Cardiovascular Pharmacology
University of California, Irvine ยท CA ยท PHARM283
Cardiovascular Pharmacology is a subject at University of California, Irvine, CA. It covers topics like cardiology, clinical-pharmacy, pathophysiology, pharmacology. It is part of 1 degree. The information below is compiled from public course material โ approximate, not official.
University of California, Irvine
PHARM283
3.00
Topics covered
Degrees that include Cardiovascular Pharmacology
Frequently asked questions
What is Cardiovascular Pharmacology about?
Cardiovascular Pharmacology covers topics like cardiology, clinical-pharmacy, pathophysiology, pharmacology.
Which degrees include Cardiovascular Pharmacology?
Cardiovascular Pharmacology is part of 1 degree, including Pharmacology, M.S..
How many credit points is Cardiovascular Pharmacology?
Cardiovascular Pharmacology at University of California, Irvine is typically around 3.00 credit points. Approximate โ confirm with the university.
Where is Cardiovascular Pharmacology taught?
Cardiovascular Pharmacology is taught at University of California, Irvine, CA.
Studying Cardiovascular Pharmacology?
Peernovo helps students research, choose and thrive at university โ across Australia, the US, the UK and Canada โ powered by our AI backbone:
- Explore & compare degrees โ across universities and countries with honest, specific information.
- "What Can I Be?" career guidance โ an AI pathway councillor that maps degrees to careers.
- See who's studying โ your degree at your university โ find classmates and study groups.
- AI Task Coach โ a Socratic study companion that plans your work around your life.
- Honours & Thesis Research Coach โ structure and move your research project forward.
- Smart study planner, exam prep and a daily digest โ to keep you on track.
Sources: University of California, Irvine public course catalogue. Information is compiled and summarised โ not copied verbatim โ and is approximate; always confirm with the original source.
Something not right on this page, or want it changed? Let us know and we'll review it.
